Publication | Open Access
A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer
35
Citations
28
References
2020
Year
The combination of guadecitabine and cisplatin was tolerable and demonstrated activity in patients with platinum refractory germ cell cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1